Guangyu Liu - Publications

Affiliations: 
2008-2013 Electrical and Computer Engineering Lehigh University, Bethlehem, PA, United States 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jia X, Li C, Li L, Zhou L, Zhang W, Ni S, Lu Y, Chen L, Jeong LS, Yu J, Zhang Y, Zhang J, He S, Hu X, Sun H, ... ... Liu G, et al. Neddylation inactivation facilitates FOXO3a nuclear export to suppress estrogen receptor transcription and improve fulvestrant sensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30833270 DOI: 10.1158/1078-0432.CCR-18-2434  0.6
2017 Cheng L, Zhang J, Wang Y, Xu X, Zhang Y, Zhang Y, Liu G, Cheng J. Textural features of (18)F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer. Annals of Nuclear Medicine. PMID 28646331 DOI: 10.1007/s12149-017-1184-1  0.6
2016 Hu S, Liu G, Chen W, Li X, Lu W, Lam RH, Fu J. Multiparametric Biomechanical and Biochemical Phenotypic Profiling of Single Cancer Cells Using an Elasticity Microcytometer. Small (Weinheim An Der Bergstrasse, Germany). PMID 26929029 DOI: 10.1002/smll.201503620  0.32
2015 Cheng J, Wang Y, Mo M, Bao X, Zhang Y, Liu G, Zhang J, Geng D. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer. Oncotarget. PMID 26336821 DOI: 10.18632/oncotarget.5001  0.6
2015 Zhang J, Wang Z, Hu X, Wang B, Wang L, Yang W, Liu Y, Liu G, Di G, Hu Z, Wu J, Shao Z. Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer. International Journal of Cancer. Journal International Du Cancer. 136: 204-11. PMID 24824628 DOI: 10.1002/ijc.28966  0.6
2014 Li X, Chen W, Liu G, Lu W, Fu J. Continuous-flow microfluidic blood cell sorting for unprocessed whole blood using surface-micromachined microfiltration membranes. Lab On a Chip. 14: 2565-75. PMID 24895109 DOI: 10.1039/c4lc00350k  0.32
2014 Sun S, Tang L, Zhang J, Lv F, Wang Z, Wang L, Zhang Q, Zheng C, Qiu L, Jia Z, Lu Y, Liu G, Shao Z, Wang B, Hu X. Cisplatin improves antitumor activity of weekly nab-paclitaxel in patients with metastatic breast cancer. International Journal of Nanomedicine. 9: 1443-52. PMID 24672237 DOI: 10.2147/IJN.S58275  0.6
2011 Zhao H, Liu G, Zhang J, Poplawsky JD, Dierolf V, Tansu N. Approaches for high internal quantum efficiency green InGaN light-emitting diodes with large overlap quantum wells. Optics Express. 19: A991-A1007. PMID 21747571  0.6
2011 Liu G, Zhao H, Zhang J, Park JH, Mawst LJ, Tansu N. Selective area epitaxy of ultra-high density InGaN quantum dots by diblock copolymer lithography. Nanoscale Research Letters. 6: 342. PMID 21711862 DOI: 10.1186/1556-276X-6-342  0.6
2002 Zhang J, Shen K, Nirmal L, Liu G, Wu J, Zhang Y, Du H, Pan Z, Shao Z, Shen Z. [Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 24: 616-8. PMID 12667340  0.6
2002 Shen K, Nirmal L, Han Q, Wu J, Lu J, Zhang J, Liu G, Shao Z, Shen Z. [Sentinel lymph node biopsy in breast cancer]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 40: 347-50. PMID 12133338  0.6
Show low-probability matches.